skip to Main Content

Among the researchers of Pomezia involved in the challenge “Definitive test in Brazil”

Rassegna stampa e tv

In the IRBM campus, the Advent’s guys cultivate cells like flowers to produce a second stock of experimental vaccine. The…

Leggi la rassegna

Italy leads the Coronavirus vaccine research

Rassegna stampa e tv

«The vaccine developed by Oxford in collaboration with an Italian company is the most advanced», said Walter Ricciardi, Advisor to…

Leggi la rassegna

Vaccine agreement. It will arrive this autumn Anglo-Italian vaccine, OK of the EU. First doses in autumn

Rassegna stampa e tv

The first doses of the vaccine produced by Oxford in collaboration with Pomezia (Rome) will arrive in Italy by autumn,…

Leggi la rassegna

Covid, a young international team: that’s how Pomezia works on the vaccine

Rassegna stampa e tv

In an 80,000 m2 site 20 miles from Rome, young researchers from around the world work day and night making…

Leggi la rassegna

«We are at the forefront in the fight against Ebola, that’s why Oxford asked Pomezia for help with the vaccine»

Rassegna stampa e tv

Everyone calls it "the Oxford/AstraZeneca vaccine”, but IRBM in Pomezia (Rome)  plays a key role in the vaccine development. This…

Leggi la rassegna

Here’s the Italian genius who’s gonna get us out of trouble

Rassegna stampa e tv

Italian Minister of Health, Roberto Speranza, announced an agreement with AstraZeneca to provide Europe with up to 400 million doses…

Leggi la rassegna

Interview with Piero Di Lorenzo, President and CEO of IRBM

Rassegna stampa e tv

The company based in Pomezia (Rome) starts the production «A great pride and a bet won» When Piero Di Lorenzo…

Leggi la rassegna
Back To Top